Real-World Data (RWD) has become an integral, inseparable element of omnichannel marketing (OCM), which is an increasingly...
In almost every therapy area, utilization management, prior authorizations, and step therapy...
There are more than 100 different types of arthritis, but osteoarthritis (OA) is the most common—impacting 32.5 Million US adults and creating an overall economic burden of...
Pre-existing condition. This is a term we heard thrown around a lot at the start of 2020. It’s still a part of our day-to-day vocabulary, especially if you're one of the...
When pharma brands become fully digitally enabled, market access pathways are optimized and providers have the tools they need to begin patients on your therapy rapidly and...
The 2022 State of Mental Health in America report highlights that 24.7% of adults with a mental illness in 2019 reported an unmet need for treatment—this number has seen a...
During the recent Digital Pharma Innovation Week, I had the great opportunity to lead a roundtable discussion with a group of stakeholders from across the pharma industry...
As pharmaceutical companies evolve toward digital-first commercial models, U.S. market access strategies seem to be lagging in the digital revolution. Companies face many...
At the recent Asembia Specialty Pharmacy Summit, I had the chance to join RxNT, a leading EHR provider, to host a small-format session on the EHR workflow. In light of recent...
There may be no greater threat to patient outcomes than the current barriers to therapy access—especially for specialty medications.
Growth in healthcare technology began with the HITECH (Health Information Technology for Economic and Clinical Health) Act of 2009 and has grown significantly over the years....
Over the past decade, pharma has made significant investments in real-world data (RWD) and in analytics/insights generated from that data. At OptimizeRx, we’re applying this...
